Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Roseamonas gilardii Bacteremia in a Patient With HbSβ0-thalassemia

Clinical Implications and Literature Review

Schlappi, Charles MD*; Bernstock, Joshua D. PhD†,‡; Ricketts, Wilson; Nix, Garrett A.; Poole, Claudette MD§; Lebensburger, Jeffrey DO, MSPH*; Friedman, Gregory K. MD*

Journal of Pediatric Hematology/Oncology: April 03, 2019 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/MPH.0000000000001476
Clinical and Laboratory Observations: PDF Only
Buy
PAP

Roseamonas gilardii is a gram-negative coccobacillus identified in immunocompromised pediatric patients. A 5-year-old male with a history of 0 thalassemia">HbSβ0 thalassemia status postsurgical splenectomy presented to the emergency department with fever. Blood cultures grew R. gilardii at 63 hours, but the patient had been discharged home at 48 hours. The patient was readmitted for repeat cultures and initiated on meropenem for 10 days as Roseamonas spp. are often resistant to third generation cephalosporins. R. gilardii is a rare cause of bacteremia in immunocompromised patients. Clinicians should consider Roseamonas in slow growing gram-negative rod bacteremias, and consider meropenem as empiric coverage.

*Department of Pediatrics, Division of Pediatric Hematology and Oncology

School of Medicine

Medical Scientist Training Program

§Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL

C.S. and J.D.B. contributed equally.

J.L. receives funding from the NIH 5K23HL127100. The remaining authors declare no conflict of interest.

Reprints: Charles Schlappi, MD, 1600 7th Ave S Lowder Bldg Suite 512, Birmingham, AL 35233 (e-mail: cwschlappi@uabmc.edu).

Received November 9, 2018

Accepted February 25, 2019

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.